Press Release Jul 16 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the closure of a Remote Regulatory Assessment by the USFDA at its Matoda facility in Gujarat. The assessment was conducted for the Prior Approval Supplement of Atorvastatin Calcium Tablets, and no observations were noted during the review. The site has been recommended for approval following the assessment, which is significant for the company's operations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 15 2025
- Press Release Jun 18 2025
- Press Release Jun 11 2025
- Press Release Jun 10 2025
- Press Release Jun 02 2025
Later from Zydus Lifesciences
- Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025
- Press Release Jul 24 2025
- Press Release Jul 29 2025
- Press Release Aug 07 2025
- Press Release Aug 08 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences